Polio Vaccine Market Updates by 2031
The Polio Vaccine Market is expected to register a CAGR of 5% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report deep-dives into the Polio Vaccine market, providing a comprehensive analysis of its current scenario, growth drivers, challenges, and future prospects. This report focuses on various issues, such as principal market trends, the competitive landscape, regional analysis, and emerging opportunities. This research aims at providing valuable insights for manufacturers, distributors, healthcare providers, and investors to make informed decisions and capitalise on the potential of the market.
Purpose of the ReportThe report Polio Vaccine Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Polio Vaccine Market Segmentation
Type- Inactivated Polio Vaccine
- Oral Polio Vaccine
- Public
- Private
Strategic Insights
Polio Vaccine Market Growth Drivers- Global Commitment to Polio Eradication: The most predominant reason is the global commitment to the polio eradication effort led by organizations like WHO and UNICEF. These entities have launched widescale immunization programs with a focus on poor populations in developing countries. This has led to a multiple-fold increase in the demand for polio vaccines.
- Increased Public Awareness of Polio: Increased awareness among the public about the severity of polio has also acted as a significant driver. Educational outreach and health programs could influence the importance of vaccinations and immunization, especially among parents and guardians. This factor has, in turn, led to increased utilization of vaccines, thus supporting market growth.
- Ample Regulatory Support: Government support and robust immunization programs have driven growth. Through allocations of sizeable funds toward immunization programs, governments around the world have kept a specific focus on the eradication of polio. This has ensured extensive access to polio vaccines across geographical boundaries, especially in low-income countries.
- Technological Advancements: Technological advancements in developing vaccines have also further boosted the market. Innovations have thus resulted in more effective and safer polio vaccines, thereby improving efficacy and reducing adverse reactions. This has brought comfort to immunization programs and increased demand. The trend of increasing healthcare expenditure is also an area in emerging economies, and this trend has positively contributed to the growth of the market. A surge in investments in preventive health care, such as vaccines, by governments and individuals has further propelled the growth of the polio vaccine market.
- Shift towards inactivated polio vaccines (IPV): With increasing instances of vaccine-derived polio infections, the focus is shifting gradually from oral polio vaccines (OPV) to IPV, which are considered safer and highly effective for long-term immunity.
- Focus on Combination Vaccines: Combination vaccines are now being developed by manufacturers in an effort to provide immunity against several diseases through a single dose, thereby reducing the total vaccination burden.
- Novel Vaccine Delivery Systems: Innovations such as microneedle patches and needle-free injectors are being developed to improve vaccine administration, especially in resource-poor areas.
- Explore New Markets: These new markets in Africa and Asia offer substantial growth prospects due to increased immunization, more healthcare spending, and more recent formulations, as in the case of oral poliovirus vaccines (OPVs) and inactivated poliovirus vaccines (IPVs).
- Strategic Partnership and Collaborations: Pharma companies, governments, and non-profit organizations can work in partnership together to hasten innovative vaccine development and marketing.
- Integration of Technology: At the same time, harnessing blockchain and artificial intelligence in vaccine supply chains will greatly enhance vaccination supply chain management, while enabling vaccine tracking and tracing, thus building strong surveillance. This opportunity offers the vaccines' stakeholders to be part of getting a polio-free world.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Polio Vaccine Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Polio Vaccine Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Polio Vaccine Market is expected to grow at a CAGR of 5% between 2023-2031
Some factors drive the Polio Vaccine market. The unrelenting efforts of a polio-free world by organizations such as the WHO and UNICEF have vastly increased demand. Public awareness through campaigns about the devastating effects of polio has led to greater vaccination. Governments supported and developed proper immunization programs, especially in developing countries, so that polio vaccines can be accessed throughout a population. Additionally, technological advancements in vaccine development have resulted in more effective and safer vaccines.
The future of the Polio Vaccine market is shaped by several key trends. As the world edges closer to polio eradication, there's a growing emphasis on maintaining high vaccination rates and addressing emerging challenges. Advancements in vaccine technology are leading to more stable and heat-tolerant vaccines, improving vaccine delivery in remote areas. Integration of polio vaccines into routine immunization programs therefore continued to be covered and protected; however, there is the potential for the emergence of vaccine-derived polioviruses, which requires continued surveillance and prompt response approaches. With the world transitioning into a polio-free era, the demand for vaccines may change, thus creating variability in planning and adaptation, both in manufacturers and health care providers.
The leading players of the market are: Bibcol, BIO-MED, GlaxoSmithKline plc, HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD, IMBCA, Panacea Biotec Ltd, Pfizer Inc, Sanofi, Serum Institute of India Pvt. Ltd., Tiantan Biological
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Polio Vaccine Market - By Type
1.3.2 Polio Vaccine Market - By Application
1.3.3 Polio Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. POLIO VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. POLIO VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. POLIO VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. POLIO VACCINE - GLOBAL MARKET OVERVIEW
6.2. POLIO VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. POLIO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. INACTIVATED POLIO VACCINE (IPV)
7.3.1. Overview
7.3.2. Inactivated Polio Vaccine (IPV) Market Forecast and Analysis
7.4. ORAL POLIO VACCINE (OPV)
7.4.1. Overview
7.4.2. Oral Polio Vaccine (OPV) Market Forecast and Analysis
8. POLIO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PUBLIC
8.3.1. Overview
8.3.2. Public Market Forecast and Analysis
8.4. PRIVATE
8.4.1. Overview
8.4.2. Private Market Forecast and Analysis
9. POLIO VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Polio Vaccine Market Overview
9.1.2 North America Polio Vaccine Market Forecasts and Analysis
9.1.3 North America Polio Vaccine Market Forecasts and Analysis - By Type
9.1.4 North America Polio Vaccine Market Forecasts and Analysis - By Application
9.1.5 North America Polio Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Polio Vaccine Market
9.1.5.1.1 United States Polio Vaccine Market by Type
9.1.5.1.2 United States Polio Vaccine Market by Application
9.1.5.2 Canada Polio Vaccine Market
9.1.5.2.1 Canada Polio Vaccine Market by Type
9.1.5.2.2 Canada Polio Vaccine Market by Application
9.1.5.3 Mexico Polio Vaccine Market
9.1.5.3.1 Mexico Polio Vaccine Market by Type
9.1.5.3.2 Mexico Polio Vaccine Market by Application
9.2. EUROPE
9.2.1 Europe Polio Vaccine Market Overview
9.2.2 Europe Polio Vaccine Market Forecasts and Analysis
9.2.3 Europe Polio Vaccine Market Forecasts and Analysis - By Type
9.2.4 Europe Polio Vaccine Market Forecasts and Analysis - By Application
9.2.5 Europe Polio Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Polio Vaccine Market
9.2.5.1.1 Germany Polio Vaccine Market by Type
9.2.5.1.2 Germany Polio Vaccine Market by Application
9.2.5.2 France Polio Vaccine Market
9.2.5.2.1 France Polio Vaccine Market by Type
9.2.5.2.2 France Polio Vaccine Market by Application
9.2.5.3 Italy Polio Vaccine Market
9.2.5.3.1 Italy Polio Vaccine Market by Type
9.2.5.3.2 Italy Polio Vaccine Market by Application
9.2.5.4 Spain Polio Vaccine Market
9.2.5.4.1 Spain Polio Vaccine Market by Type
9.2.5.4.2 Spain Polio Vaccine Market by Application
9.2.5.5 United Kingdom Polio Vaccine Market
9.2.5.5.1 United Kingdom Polio Vaccine Market by Type
9.2.5.5.2 United Kingdom Polio Vaccine Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Polio Vaccine Market Overview
9.3.2 Asia-Pacific Polio Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Polio Vaccine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Polio Vaccine Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Polio Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Polio Vaccine Market
9.3.5.1.1 Australia Polio Vaccine Market by Type
9.3.5.1.2 Australia Polio Vaccine Market by Application
9.3.5.2 China Polio Vaccine Market
9.3.5.2.1 China Polio Vaccine Market by Type
9.3.5.2.2 China Polio Vaccine Market by Application
9.3.5.3 India Polio Vaccine Market
9.3.5.3.1 India Polio Vaccine Market by Type
9.3.5.3.2 India Polio Vaccine Market by Application
9.3.5.4 Japan Polio Vaccine Market
9.3.5.4.1 Japan Polio Vaccine Market by Type
9.3.5.4.2 Japan Polio Vaccine Market by Application
9.3.5.5 South Korea Polio Vaccine Market
9.3.5.5.1 South Korea Polio Vaccine Market by Type
9.3.5.5.2 South Korea Polio Vaccine Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Polio Vaccine Market Overview
9.4.2 Middle East and Africa Polio Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Polio Vaccine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Polio Vaccine Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Polio Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Polio Vaccine Market
9.4.5.1.1 South Africa Polio Vaccine Market by Type
9.4.5.1.2 South Africa Polio Vaccine Market by Application
9.4.5.2 Saudi Arabia Polio Vaccine Market
9.4.5.2.1 Saudi Arabia Polio Vaccine Market by Type
9.4.5.2.2 Saudi Arabia Polio Vaccine Market by Application
9.4.5.3 U.A.E Polio Vaccine Market
9.4.5.3.1 U.A.E Polio Vaccine Market by Type
9.4.5.3.2 U.A.E Polio Vaccine Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Polio Vaccine Market Overview
9.5.2 South and Central America Polio Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Polio Vaccine Market Forecasts and Analysis - By Type
9.5.4 South and Central America Polio Vaccine Market Forecasts and Analysis - By Application
9.5.5 South and Central America Polio Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Polio Vaccine Market
9.5.5.1.1 Brazil Polio Vaccine Market by Type
9.5.5.1.2 Brazil Polio Vaccine Market by Application
9.5.5.2 Argentina Polio Vaccine Market
9.5.5.2.1 Argentina Polio Vaccine Market by Type
9.5.5.2.2 Argentina Polio Vaccine Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. POLIO VACCINE MARKET, KEY COMPANY PROFILES
11.1. BIBCOL
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BIO-MED
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. IMBCA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PANACEA BIOTEC LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. PFIZER INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANOFI
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SERUM INSTITUTE OF INDIA PVT. LTD.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TIANTAN BIOLOGICAL
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Bibcol
2. BIO-MED
3. GlaxoSmithKline plc
4. HAFFKINE BIO-PHARMACEUTICAL CORPORATION LTD
5. IMBCA
6. Panacea Biotec Ltd
7. Pfizer Inc
8. Sanofi
9. Serum Institute of India Pvt. Ltd.
10. Tiantan Biological
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For